rp OTCMKTS:PMCB - News Headlines for Pharmacyte Biotech | MarketBeat

OTCMKTS:PMCB - Pharmacyte Biotech News Headlines

$0.0371
0.00 (0.00 %)
(As of 06/17/2019 12:57 PM ET)
Today's Range
$0.0367
Now: $0.0371
$0.0395
50-Day Range
$0.0370
MA: $0.04
$0.0420
52-Week Range
$0.0350
Now: $0.0371
$0.0885
Volume334,348 shs
Average Volume1.46 million shs
Market Capitalization$43.07 million
P/E RatioN/A
Dividend YieldN/A
Beta2.07

Headlines

Pharmacyte Biotech (OTCMKTS PMCB) News Headlines

Source:
DateHeadline
PharmaCyte Biotech CEO Visiting GMP Facility with Cellular Biology Consultant During Production of Pancreatic Cancer ProductPharmaCyte Biotech CEO Visiting GMP Facility with Cellular Biology Consultant During Production of Pancreatic Cancer Product
finance.yahoo.com - June 3 at 3:22 PM
Head-To-Head Comparison: Organovo (ONVO) versus Pharmacyte Biotech (PMCB)Head-To-Head Comparison: Organovo (ONVO) versus Pharmacyte Biotech (PMCB)
www.americanbankingnews.com - May 28 at 6:14 PM
PharmaCyte Biotech Proceeding with GMP Production of Pancreatic Cancer Product After Successful Changes to Manufacturing ProcessPharmaCyte Biotech Proceeding with GMP Production of Pancreatic Cancer Product After Successful Changes to Manufacturing Process
finance.yahoo.com - May 20 at 3:36 PM
PharmaCyte Biotech Bioengineers Cell Line for Cannabis Program to Treat CancersPharmaCyte Biotech Bioengineers Cell Line for Cannabis Program to Treat Cancers
finance.yahoo.com - May 13 at 3:34 PM
PharmaCyte Biotech Advances Manufacturing Process for Clinical Trial in Pancreatic CancerPharmaCyte Biotech Advances Manufacturing Process for Clinical Trial in Pancreatic Cancer
finance.yahoo.com - May 6 at 3:24 PM
PharmaCyte Nears Major MilestonePharmaCyte Nears Major Milestone
www.baystreet.ca - February 4 at 3:16 PM
PharmaCyte Biotech Nearing Major Milestone—An Open IND with the FDAPharmaCyte Biotech Nearing Major Milestone—An Open IND with the FDA
finance.yahoo.com - February 4 at 3:16 PM
PharmaCyte Biotech Releases CEO Interview from The Big Biz ShowPharmaCyte Biotech Releases CEO Interview from The Big Biz Show
finance.yahoo.com - January 22 at 3:16 PM
PharmaCyte Biotech’s CEO Interviewing Live on The Big Biz ShowPharmaCyte Biotech’s CEO Interviewing Live on The Big Biz Show
finance.yahoo.com - January 17 at 3:32 PM
PharmaCyte Biotech Announces Encapsulation of Live Cells for Clinical Trial in Pancreatic CancerPharmaCyte Biotech Announces Encapsulation of Live Cells for Clinical Trial in Pancreatic Cancer
finance.yahoo.com - January 15 at 3:23 PM
PharmaCyte Biotech Engages cGMP Validation to Assist in Preparation of IND for Pancreatic Cancer TrialPharmaCyte Biotech Engages cGMP Validation to Assist in Preparation of IND for Pancreatic Cancer Trial
finance.yahoo.com - December 4 at 9:40 AM
PharmaCyte Biotech Completes Report of FDA Required Study Assessing Safety of Placement of Its Pancreatic Cancer ProductPharmaCyte Biotech Completes Report of FDA Required Study Assessing Safety of Placement of Its Pancreatic Cancer Product
finance.yahoo.com - November 15 at 3:20 PM
PharmaCyte Biotech Selects Medpace as CRO for Its Clinical Trial in Pancreatic CancerPharmaCyte Biotech Selects Medpace as CRO for Its Clinical Trial in Pancreatic Cancer
finance.yahoo.com - November 6 at 3:22 PM
PharmaCyte Biotech Announces Publication of United States Patent Application for Cancer TherapiesPharmaCyte Biotech Announces Publication of United States Patent Application for Cancer Therapies
finance.yahoo.com - October 30 at 3:17 PM
PharmaCyte Biotech Announces Publication of PCT Patent Application for Cancer TherapiesPharmaCyte Biotech Announces Publication of PCT Patent Application for Cancer Therapies
finance.yahoo.com - October 9 at 3:11 PM
PharmaCyte Bio up 8% on advancement toward clinical study of novel cancer treatmentPharmaCyte Bio up 8% on advancement toward clinical study of novel cancer treatment
seekingalpha.com - October 1 at 3:13 PM
PharmaCyte Biotech (PMCB) Announces Complete Crucial FDA-Required Study for Pancreatic Cancer TrialPharmaCyte Biotech (PMCB) Announces Complete Crucial FDA-Required Study for Pancreatic Cancer Trial
www.streetinsider.com - October 1 at 3:13 PM
PharmaCyte Biotech Reports Completion of Crucial FDA-Required Study for Pancreatic Cancer TrialPharmaCyte Biotech Reports Completion of Crucial FDA-Required Study for Pancreatic Cancer Trial
finance.yahoo.com - October 1 at 3:13 PM
PharmaCyte Biotech Successfully Completes Comparative Analysis of Methods for Measuring Viability of Encapsulated CellsPharmaCyte Biotech Successfully Completes Comparative Analysis of Methods for Measuring Viability of Encapsulated Cells
finance.yahoo.com - September 27 at 3:16 PM
PharmaCyte Biotech Successfully Completes Final Pre-Production Run of Pancreatic Cancer ProductPharmaCyte Biotech Successfully Completes Final Pre-Production Run of Pancreatic Cancer Product
finance.yahoo.com - September 18 at 3:25 PM
PharmaCyte Biotech Successfully Completes Another Study on the Encapsulated Cells Used in Its Pancreatic Cancer TherapyPharmaCyte Biotech Successfully Completes Another Study on the Encapsulated Cells Used in Its Pancreatic Cancer Therapy
finance.yahoo.com - July 23 at 5:00 PM
PharmaCyte Biotech Discusses Importance of Shrinking Pancreatic Cancer Tumors in Latest Q&A SeriesPharmaCyte Biotech Discusses Importance of Shrinking Pancreatic Cancer Tumors in Latest Q&A Series
finance.yahoo.com - June 28 at 3:27 PM
PharmaCyte Biotech Inc. (PMCB) Completes FDA Required Study Necessary for Submitting Investigational NDAPharmaCyte Biotech Inc. (PMCB) Completes FDA Required Study Necessary for Submitting Investigational NDA
www.streetinsider.com - June 16 at 9:41 AM
PharmaCyte Biotech Successfully Completes Another FDA Required Study Necessary for Submitting Investigational New Drug ApplicationPharmaCyte Biotech Successfully Completes Another FDA Required Study Necessary for Submitting Investigational New Drug Application
finance.yahoo.com - June 14 at 10:30 AM
PharmaCyte Biotech Receives Certificates of Analysis from Eurofins on Cells Used for Pancreatic Cancer TherapyPharmaCyte Biotech Receives Certificates of Analysis from Eurofins on Cells Used for Pancreatic Cancer Therapy
finance.yahoo.com - June 1 at 3:22 PM
PharmaCyte Biotech CEO and CSO Interviewed About IND, Planned Clinical Trial in Pancreatic Cancer, CRO and MorePharmaCyte Biotech CEO and CSO Interviewed About IND, Planned Clinical Trial in Pancreatic Cancer, CRO and More
finance.yahoo.com - May 30 at 3:25 PM
PharmaCyte Closing in on Submission of Crucial Investigational New Drug Application to Begin Clinical Trial in Pancreatic CancerPharmaCyte Closing in on Submission of Crucial Investigational New Drug Application to Begin Clinical Trial in Pancreatic Cancer
finance.yahoo.com - May 21 at 3:19 PM
PharmaCyte Biotech Successfully Completes 29 Tests Conducted on Live Cells Used in Pancreatic Cancer TherapyPharmaCyte Biotech Successfully Completes 29 Tests Conducted on Live Cells Used in Pancreatic Cancer Therapy
finance.yahoo.com - May 16 at 3:25 PM
PharmaCyte Biotech Successfully Completes Pore Size Studies in Cell-in-a-Box® Capsules Used in Pancreatic Cancer TherapyPharmaCyte Biotech Successfully Completes Pore Size Studies in Cell-in-a-Box® Capsules Used in Pancreatic Cancer Therapy
finance.yahoo.com - May 9 at 3:22 PM
PharmaCyte Biotech Reports Successful Completion of Long-term Studies on Cells Used in Pancreatic Cancer TherapyPharmaCyte Biotech Reports Successful Completion of Long-term Studies on Cells Used in Pancreatic Cancer Therapy
finance.yahoo.com - April 30 at 3:19 PM
PharmaCyte Biotech Successfully Completes Multiple Course Ifosfamide StudyPharmaCyte Biotech Successfully Completes Multiple Course Ifosfamide Study
finance.yahoo.com - April 17 at 10:39 AM
PharmaCyte’s Clinical Trial Cells Arrive Safely at Austrianova’s Encapsulation FacilityPharmaCyte’s Clinical Trial Cells Arrive Safely at Austrianova’s Encapsulation Facility
finance.yahoo.com - April 5 at 9:29 AM
PharmaCyte Ships Clinical Trial Cells to Austrianova for EncapsulationPharmaCyte Ships Clinical Trial Cells to Austrianova for Encapsulation
finance.yahoo.com - April 2 at 3:22 PM
PharmaCyte Biotech Files Patent Applications to Broaden Protection of Cancer Therapy in U.S. and WorldwidePharmaCyte Biotech Files Patent Applications to Broaden Protection of Cancer Therapy in U.S. and Worldwide
finance.yahoo.com - March 26 at 3:19 PM
PharmaCyte Discusses Phase 2b Clinical Trial in Pancreatic CancerPharmaCyte Discusses Phase 2b Clinical Trial in Pancreatic Cancer
finance.yahoo.com - February 28 at 3:23 PM
PharmaCyte Announces Successful Completion of 6-Month Stability Study on Encapsulated Cells for Clinical TrialPharmaCyte Announces Successful Completion of 6-Month Stability Study on Encapsulated Cells for Clinical Trial
finance.yahoo.com - February 26 at 3:13 PM
PharmaCyte Announces Completion of Preparatory Work and Commencement of Testing by Eurofins of Cells from Its Master Cell BankPharmaCyte Announces Completion of Preparatory Work and Commencement of Testing by Eurofins of Cells from Its Master Cell Bank
finance.yahoo.com - February 6 at 3:15 PM
PharmaCyte Announces Completion of Master Cell BankPharmaCyte Announces Completion of Master Cell Bank
finance.yahoo.com - January 10 at 5:49 PM
PharmaCyte Biotech Meets with Oncology Advisory BoardPharmaCyte Biotech Meets with Oncology Advisory Board
finance.yahoo.com - December 11 at 9:35 AM
PharmaCyte Biotech Announces Production of Master Cell BankPharmaCyte Biotech Announces Production of Master Cell Bank
finance.yahoo.com - December 5 at 9:17 AM
PharmaCyte Biotech Announces Successful Completion of Cell Testing for Production of Master Cell BankPharmaCyte Biotech Announces Successful Completion of Cell Testing for Production of Master Cell Bank
finance.yahoo.com - November 28 at 10:36 AM
British Columbia Securities Commission Revokes Cease Trade Order on PharmaCyte Biotech SecuritiesBritish Columbia Securities Commission Revokes Cease Trade Order on PharmaCyte Biotech Securities
finance.yahoo.com - November 18 at 10:59 AM
PharmaCyte Biotech Releases Shareholder Call Playback InformationPharmaCyte Biotech Releases Shareholder Call Playback Information
finance.yahoo.com - November 4 at 8:59 AM
PharmaCyte Biotech Update on Shareholder CallPharmaCyte Biotech Update on Shareholder Call
finance.yahoo.com - October 27 at 10:46 AM
PharmaCyte Biotech to Hold Shareholder CallPharmaCyte Biotech to Hold Shareholder Call
finance.yahoo.com - October 21 at 8:15 AM
PharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight CancerPharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight Cancer
finance.yahoo.com - October 17 at 4:08 PM
PharmaCyte Biotech Appoints Alan Morell of Creative Management Partners as Strategic AdvisorPharmaCyte Biotech Appoints Alan Morell of Creative Management Partners as Strategic Advisor
finance.yahoo.com - September 14 at 9:16 AM
PharmaCyte Restructures Agreements with Austrianova to Strengthen PartnershipPharmaCyte Restructures Agreements with Austrianova to Strengthen Partnership
finance.yahoo.com - September 7 at 7:41 AM
PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical OfficerPharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer
finance.yahoo.com - August 3 at 11:09 AM
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel